DexCom Deals Integrate Glucose Monitor With Insulin Pumps
This article was originally published in The Gray Sheet
Executive Summary
Continuous glucose monitor manufacturer DexCom announced two agreements last week to combine its technology with insulin pumps. The moves could improve the firm's competitive position against Medtronic, the only company that currently offers an FDA-approved integrated CGM-pump device
You may also be interested in...
New Products In Brief
J&J/Codman’s Orbit Galaxy
New Products In Brief
J&J/Codman’s Orbit Galaxy
Medtronic Diabetes Pipeline Includes Insulin Patch, Next-Gen CGM
Medtronic is aiming to submit a 510(k) application to FDA for its patch-based insulin delivery device by year-end, setting the stage for a mid-2010 U.S. launch